secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartBeam, Inc. (BEAT)
CIK:        0001779372
Form:       8-K
Filed at:   2022-08-08T23:59:59+00:00
Accession:  0001779372-22-000033
Event type: leadership
Sentiment:  positive
Materiality: 0.50
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HeartBeam appoints Ken Persen as CTO; enters LIVMOR partnership amendment
-------------------------------------------------------------------------

- Ken Persen named CTO effective Aug 2, 2022; $300k annual salary, bonus up to 30% tied to FDA submission and corporate goals, 80k stock option.
- Entered supplemental agreement with LIVMOR: paid $200k for source code access; licenses become non-exclusive, perpetual, royalty-free.
- Persen previously LIVMOR CTO/CEO; over 28 years in cardiac devices and digital health, including Guidant and Cameron Health.
- Partnership to create a company-branded version of LIVMOR's Halo+ remote patient monitoring solution for physicians and patients.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779372/000177937222000033/0001779372-22-000033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779372/000177937222000033/beat-20220802.htm
  HTML page:      https://secwatch.observer/filing/0001779372-22-000033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer